Current Trends in Pharmacovigilance

-
Pharmacovigilance, also known as drug safety, is the pharmacological science relating to the collection, detection assessment, monitoring and prevention of adverse effects with pharmaceutical products.The latest news is the outbreak of coronavirus which has been declared as the global emergency, by WHO, as it could spread to countries with fragile health systems. The scientists from china isolated the virus but didn’t share the sample, but the virus genetic sequence has been made available to the international researchers. However, researchers from Melbourne has isolated the virus from the first diagnosed person with infection in Australia. Now, this sample has been shared to the research labs around the world (recommended by WHO) to develop the accurate diagnostic tests and vaccines. This infection can be treated in two ways: antivirals and antibody vaccines but the most reliable method (in aspect of time and efficacy) vaccines are more preferable. Many companies are ready and agreed to perform the trails and produce the medicines to forbid the virus becoming an endemic infection.

And according to the latest news as on 31 January 2020, a doctor from Tamil Nadu state claims that his knowledge in siddha and Ayurvedic medicines can help in curing the corona virus fever with the herbal extract which is used to treat dengue, multi-organ fever and acute liver fever." "We want to tell the World Health Organization (WHO) and the Chinese government that our medicine is very effective in treating multi-organ failure in corona fever condition," he said.










New rules for clinical trials and their effect:
India’s Ministry of Health and Family Welfare (MoHFW) has published the final version of New Drugs and Clinical Trials Rules, 2019. The new regulations cover provision for promoting clinical research as well as complex topics such as orphan drug, post-trial access, and pre and post-submission meeting. The new rules appear comprehensive, well-balanced, and likely to improve the ethical and quality standards of clinical trials in India, which will further benefit patients and industry. 
These rules will help, to provide patients with earlier access to drugs and also speed up the trial process and encourage local drug development. Provision for accelerated product approval under some conditions, especially pre and post-submission meetings with authorities, may add increased predictability and confidence in the system.

Comments

Post a Comment

Popular posts from this blog

Cold Chain in Vaccine Rollout: from COVID-19 Pandemic Perspective

-
Image
 It had been a year since the Novel Corona Virus (COVID-19) outbreak happened. Scientists had continuously strived to invent a vaccine, and finally, many pharmaceutical companies are coming up with their interventions. With the few of the clinical trials coming to a climax, the Pharma companies and Governments are pondering on the distribution of vaccines to billions of people and their supply chain management which poses as one of the major challenges. From the time of manufacture till distribution, vaccines must be continuously stored in a limited temperature range, according to the type of vaccine. Different vaccines have different storage conditions like ambient, freeze-sensitive or frozen. Since vaccines are parenteral, optimal temperature and storage are to be taken care of to prevent any leakage and decrease in the efficacy of the vaccine. In order to tackle this challenge, WHO has recommended certain ‘cold chain’ principles to manage the vaccine roll out? A temperature-controll
Read more

Effect of Lockdown on Clinical Trials

-
Image
The pandemic lockdown and quarantine has slowed down or in some cases paused most of our everyday lives. With daily routines affected, there is a butterfly the effect that ended up affecting most professions in some or the other way- including the clinical research industry.                                   With the whole world focusing on COVID19 research , much of non-COVID19 related ongoing and upcoming projects have taken a backseat – especially, in-person operations. This doesn’t necessarily mean a complete halt in the research process, regulatory bodies like USFDA have issued guidelines on conduct of clinical trials during COVID-19 pandemic. Although these guidelines are designed to tackle current pandemic, these changes are bound to have short term implications that could potentially shift the way in which the industry functions in the long term. Effects on research operations/procedures/ trial progress: Trial sites that have been transformed or dedicated for CO
Read more

“Real World Evidence from Retrospective Study: A New Approach”

-
Image
Choosing the best accessible therapeutic and preventive measures to avoid suffering from diseases leading to disability and death is an important goal for all health care professionals. To accomplish this objective, the health care community seeks information on data to support critical decision making while choosing interventions during clinical practice.   A retrospective clinical study looks backward in time, usually using the medical records and interviews with patients who are already known to have a medical condition. The study looks backward and examines exposures to suspected risk or protection factors in relation to an outcome which is established at the beginning of the study. A “ Retrospective study ” is played out a posteriori, utilizing data on occasions that have occurred previously. In most cases, some or most of the information has just been assembled and put away in the library. In a retrospective study, different patient populations can be compared to one or severa
Read more